StockData
Alignment Healthcare, Inc. logo

Alignment Healthcare, Inc. (ALHC) shareholders

ALHCNasdaqHospital & Medical Service PlansFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3053% above fair value
$6.72−0.90 (-11.81%)

Close on Nov 18, 2026Market cap $1.41BP/E 61.1Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
222M of 209M shares
Institutional holders
323
80 new, 46 sold out
Net institutional buying
21M
In Q2 2026
Insider trades, 12 months
1 buys · 78 sales
Net sold $517.47M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
General Atlantic Partners 95, L.P.
Joint filing with General Atlantic, L.P. (22.20%), GAPCO GmbH & Co. KG (22.20%) and 8 more
43,993,32322.20%13G (passive) amendmentJun 30, 2025
General Atlantic (SPV) GP, LLC
Joint filing with General Atlantic, L.P. (12.30%), General Atlantic Partners 95, L.P. (12.30%) and 8 more
24,287,22712.30%13G (passive) amendmentSep 17, 2025
BlackRock, Inc.23,530,37311.30%13G (passive) amendmentSep 30, 2026
Wellington Investment Advisors Holdings LLP
Joint filing with Wellington Management Group LLP (8.40%), Wellington Group Holdings LLP (8.40%) and 1 more
17,098,9368.40%13G (passive) amendmentMar 31, 2026
Abigail P. Johnson
Joint filing with FMR LLC (7.70%)
14,792,0827.70%13G (passive)Dec 31, 2025
Wellington Group Holdings LLP
Joint filing with Wellington Management Group LLP (7.30%), Wellington Investment Advisors Holdings LLP (7.30%) and 1 more
14,070,8937.30%13G (passive) amendmentDec 31, 2025
Q Healthcare Holding LLC
Joint filing with Qatar Investment Authority (6.69%)
13,246,0966.69%13G (passive)Sep 17, 2025
GAPCO Management GmbH
Joint filing with General Atlantic, L.P. (6.60%), General Atlantic Partners 95, L.P. (6.60%) and 8 more
13,167,7336.60%13G (passive) amendmentDec 31, 2025
T. Rowe Price Investment Management, Inc.12,331,7206.20%13G (passive)Jun 30, 2025
Vanguard Portfolio Management11,874,5855.74%13G (passive)Jun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ALHCValueChange% of portfolio
BlackRock, Inc.19,342,9569.24%$460.56M+5,267,7590.01%
Wellington Management Group Llp18,780,3638.97%$447.16M+1,681,4270.08%
FMR LLC13,924,3296.65%$331.54M−1,967,7350.01%
T. Rowe Price Investment Management, Inc.13,119,5576.27%$312.38M−28,0990.20%
Vanguard Portfolio Management LLC11,672,2595.58%$277.92M+1,962,1880.01%
Invesco Ltd.10,365,6404.95%$246.81M+3,365,5410.02%
Bank Of America Corp /De/9,346,7424.47%$222.55M+6,131,0750.01%
Vanguard Capital Management LLC8,144,2473.89%$193.91M+170,5840.00%
William Blair Investment Management, LLC7,761,4033.71%$184.80M+2,546,7890.56%
State Street Corp7,297,4943.49%$173.75M+3,003,8000.01%
Hood River Capital Management LLC6,184,5262.96%$147.25M+130,0491.07%
Price T Rowe Associates Inc /Md/4,939,1452.36%$117.60M−802,1610.01%
Geode Capital Management, LLC4,845,5102.32%$115.39M+434,1700.01%
Capital Research Global Investors4,399,3292.10%$104.75M+805,7530.01%
Goldman Sachs Group Inc4,013,3391.92%$95.56M+3,001,6890.01%
Capital World Investors3,910,1311.87%$93.10M+1,244,0730.01%
Danica Pension, Livsforsikringsaktieselskab3,687,2591.76%$87.79M+1,183,6821.40%
Bank of New York Mellon Corp3,657,1601.75%$87.08M+344,0500.01%
Allspring Global Investments Holdings, LLC3,053,5251.46%$73.32M+595,1250.11%
Next Century Growth Investors LLC2,537,5981.21%$60.42M+275,5223.20%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026323222M100.0%80 / 14281 / 4653M32M
Q1 2026293202M96.4%77 / 11175 / 4253M28M
Q4 2025263193M92.4%55 / 12863 / 2538M28M
Q3 2025236184M88.1%55 / 9770 / 3536M40M
Q2 2025217188M90.1%53 / 10250 / 4144M38M
Q1 2025207183M87.4%53 / 9542 / 1724M17M
Q4 2024172176M84.3%47 / 6638 / 1130M21M
Q3 2024137167M79.8%30 / 4542 / 1019M12M
Q2 2024118168M80.3%19 / 5234 / 3012M9M
Q1 2024130165M78.8%28 / 3645 / 1914M13M
Q4 2023121164M78.2%10 / 4148 / 206M4M
Q3 2023131162M77.3%18 / 5043 / 275M5M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

364 funds held ALHC in Q2 2026, 31% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ALHCValue% of fundAs of
SMALLCAP World Fund Inc7,393,7263.53%$176.04M0.19%Jun 30, 2026
Vanguard Health Care Fund6,928,0073.31%$102.88M0.27%Jul 31, 2026
Vanguard Total Stock Market Index Fund5,893,8982.82%$140.33M0.01%Jun 30, 2026
iShares Russell 2000 ETF4,587,5282.19%$109.23M0.13%Jun 30, 2026
iShares Core S&P Small-Cap ETF4,555,2442.18%$108.46M0.10%Jun 30, 2026
Invesco Discovery Fund4,299,0862.05%$65.86M0.84%May 31, 2026
Vanguard Small-Cap Index Fund4,268,7082.04%$101.64M0.05%Jun 30, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.4,164,5401.99%$99.16M1.07%Jun 30, 2026
Hood River Small-Cap Growth Fund4,079,1241.95%$97.12M1.46%Jun 30, 2026
Select Health Care Portfolio2,600,0001.24%$39.83M0.69%May 31, 2026
Vanguard Small-Cap Growth Index Fund2,457,9661.17%$58.52M0.12%Jun 30, 2026
T. Rowe Price Institutional Small-Cap Stock Fund2,270,5631.09%$54.06M1.08%Jun 30, 2026
Fidelity Small Cap Index Fund2,232,6751.07%$33.16M0.10%Jul 31, 2026
T. Rowe Price New Horizons Fund, Inc.2,190,0751.05%$52.15M0.35%Jun 30, 2026
T. Rowe Price Small-Cap Value Fund, Inc.2,016,7670.96%$48.02M0.45%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Joseph S. KonowieckiEVP, Corporate Affairs, Director1,075,3750.51%Nov 12, 2026
John E. KaoChief Executive Officer, Director1,814,2390.87%Sep 16, 2026
Hyong KimChief Medical Officer299,2710.14%Oct 7, 2026
Dawn Christine MaroneyPresident794,6060.38%Sep 11, 2026
Shane J. HochradelChief Operations Officer87,7190.04%Jul 2, 2026
Mark D. KentPresident - MSO102,5670.05%Jun 9, 2026
James M. HeadChief Financial Officer173,4950.08%Apr 8, 2026
Christopher J. JoyceChief Legal and Admin. Officer305,4510.15%Apr 1, 2026
Sebastian BurzacchiCOO - Mgmt Services Org258,6300.12%Mar 19, 2026
Robert L. ScavoChief Information Officer487,6850.23%Mar 19, 2026
Andreas P. WagnerChief Human Resources Officer148,6280.07%Mar 19, 2026
Adnan R. MansourChief Digital Officer48,4560.02%Mar 17, 2026
Hakan KardesChief Experience Officer678,9870.32%Mar 28, 2025
Robert Thomas FreemanChief Financial Officer1,557,3480.74%Mar 28, 2025
Mark B. McClellanDirector370,5310.18%Mar 17, 2026
Yon JordenDirector105,8300.05%Mar 17, 2026
Nicholas Robbert VorhoffDirector173,4080.08%Mar 17, 2026
Jacqueline B. KosecoffDirector303,9630.15%Mar 17, 2026
Margaret M. McCarthyDirector144,4410.07%Mar 17, 2026
Jody L. BilneyDirector129,2670.06%Mar 17, 2026
David C. HodgsonDirector173,4080.08%Mar 17, 2026
GAP Coinvestments V, LLC10% owner61,302,17529.29%Dec 12, 2025
Gmbh & Co Kg Gapco10% owner78,511,41137.52%Dec 12, 2025
General Atlantic, L.P.10% owner76,328,61536.47%Dec 12, 2025
GAP Coinvestments CDA, L.P.10% owner30,842,17514.74%Dec 12, 2025
Gap Coinvestments Iv, Llc10% owner––Dec 12, 2025
General Atlantic Genpar, L.P.10% owner13,476,5856.44%Dec 12, 2025
Gap Coinvestments Iii, Llc10% owner––Dec 12, 2025
General Atlantic Partners 95, L.P.10% owner24,596,07911.75%Dec 12, 2025
General Atlantic (SPV) GP, LLC10% owner67,949,31732.47%Dec 12, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Joseph S. Konowiecki
EVP, Corporate Affairs, Director
Nov 10, 2026Sale−4,930$7.20$35.50K1,075,375
Hyong Kim
Chief Medical Officer
Oct 6, 2026Sale−32,479$8.30$269.58K299,271
Joseph S. Konowiecki
EVP, Corporate Affairs, Director
Sep 17, 2026Sale−23,511$8.61$202.43K1,080,305
John E. Kao
Chief Executive Officer, Director
Sep 14, 2026Sale(10b5-1 plan)−27,400$13.00$356.20K590,766
Dawn Christine Maroney
President
Sep 11, 2026Sale−122,707$12.68$1.56M794,606
John E. Kao
Chief Executive Officer, Director
Sep 11, 2026Sale(10b5-1 plan)−385,270$12.68$4.89M1,223,473
John E. Kao
Chief Executive Officer, Director
Sep 10, 2026Sale(10b5-1 plan)−172,600$12.96$2.24M618,166
Dawn Christine Maroney
President
Aug 14, 2026Sale(10b5-1 plan)−5,000$14.00$70.00K917,313
John E. Kao
Chief Executive Officer, Director
Aug 10, 2026Sale(10b5-1 plan)−298,000$13.88$4.14M790,766
Dawn Christine Maroney
President
Jul 15, 2026Option exercise+152,068$9.06$1.38M1,099,381
Dawn Christine Maroney
President
Jul 15, 2026Sale(10b5-1 plan)−177,068$20.83$3.69M922,313
John E. Kao
Chief Executive Officer, Director
Jul 10, 2026Sale(10b5-1 plan)−18,356$20.65$379.05K1,088,766
John E. Kao
Chief Executive Officer, Director
Jul 10, 2026Sale(10b5-1 plan)−279,644$19.81$5.54M1,107,122
Shane J. Hochradel
Chief Operations Officer
Jul 1, 2026Award+87,719––87,719
Joseph S. Konowiecki
EVP, Corporate Affairs, Director
Jul 1, 2026Sale(10b5-1 plan)−25,000$24.00$600.00K1,103,816
Joseph S. Konowiecki
EVP, Corporate Affairs, Director
Jun 26, 2026Sale(10b5-1 plan)−25,000$23.00$575.00K1,128,816
Joseph S. Konowiecki
EVP, Corporate Affairs, Director
Jun 18, 2026Sale(10b5-1 plan)−25,000$22.00$550.00K1,153,816
Dawn Christine Maroney
President
Jun 15, 2026Sale(10b5-1 plan)−30,000$19.55$586.50K947,313
Hyong Kim
Chief Medical Officer
Jun 12, 2026Sale(10b5-1 plan)−35,951$19.86$713.99K331,750
Joseph S. Konowiecki
EVP, Corporate Affairs, Director
Jun 11, 2026Sale(10b5-1 plan)−25,000$21.00$525.00K1,178,816
John E. Kao
Chief Executive Officer, Director
Jun 10, 2026Sale(10b5-1 plan)−223,064$20.60$4.60M1,386,766
John E. Kao
Chief Executive Officer, Director
Jun 10, 2026Sale(10b5-1 plan)−74,936$19.65$1.47M1,609,830
Mark D. Kent
President - MSO
Jun 3, 2026Award+87,719––102,567
Joseph S. Konowiecki
EVP, Corporate Affairs, Director
Jun 3, 2026Award+122,807––1,203,816
Mark D. Kent
President - MSO
Jun 2, 2026Buy+14,848$13.31$197.63K14,848
Dawn Christine Maroney
President
May 18, 2026Gift−20,000––977,313
Dawn Christine Maroney
President
May 15, 2026Sale(10b5-1 plan)−30,000$16.09$482.70K998,813
Dawn Christine Maroney
President
May 15, 2026Gift−1,500––997,313
John E. Kao
Chief Executive Officer, Director
May 11, 2026Sale(10b5-1 plan)−17,107$17.54$300.06K1,508,641
John E. Kao
Chief Executive Officer, Director
May 11, 2026Sale(10b5-1 plan)−280,893$16.85$4.73M1,525,748
Dawn Christine Maroney
President
Apr 15, 2026Sale(10b5-1 plan)−30,000$20.87$626.10K1,028,813
John E. Kao
Chief Executive Officer, Director
Apr 13, 2026Sale(10b5-1 plan)−82,299$20.80$1.71M1,806,641
John E. Kao
Chief Executive Officer, Director
Apr 10, 2026Sale(10b5-1 plan)−13,801$21.38$295.07K1,888,940
John E. Kao
Chief Executive Officer, Director
Apr 10, 2026Sale(10b5-1 plan)−201,900$20.58$4.16M1,902,741
James M. Head
Chief Financial Officer
Apr 7, 2026Sale−11,100$21.08$233.99K173,495
John E. Kao
Chief Executive Officer, Director
Apr 7, 2026Sale(10b5-1 plan)−132,241$20.67$2.73M2,222,400
John E. Kao
Chief Executive Officer, Director
Apr 7, 2026Sale(10b5-1 plan)−117,759$21.40$2.52M2,104,641
Christopher J. Joyce
Chief Legal and Admin. Officer
Apr 1, 2026Sale(10b5-1 plan)−18,013$17.79$320.45K305,451
John E. Kao
Chief Executive Officer, Director
Mar 23, 2026Sale(10b5-1 plan)−118,000$17.48$2.06M2,354,641
Andreas P. Wagner
Chief Human Resources Officer
Mar 19, 2026Sale(10b5-1 plan)−11,602$18.22$211.39K148,628
Christopher J. Joyce
Chief Legal and Admin. Officer
Mar 18, 2026Sale−25,125$17.84$448.23K323,464
Dawn Christine Maroney
President
Mar 18, 2026Sale−36,749$17.84$655.60K1,058,813
Sebastian Burzacchi
COO - Mgmt Services Org
Mar 18, 2026Sale−15,361$17.84$274.04K258,630
Hyong Kim
Chief Medical Officer
Mar 18, 2026Sale−18,404$17.84$328.33K367,701
Andreas P. Wagner
Chief Human Resources Officer
Mar 18, 2026Sale(10b5-1 plan)−12,000$17.84$214.08K160,230
John E. Kao
Chief Executive Officer, Director
Mar 18, 2026Sale−73,046$17.84$1.30M1,784,868
Robert L. Scavo
Chief Information Officer
Mar 18, 2026Sale−11,285$17.84$201.32K487,685
Dawn Christine Maroney
President
Mar 16, 2026Sale(10b5-1 plan)−30,000$17.48$524.40K1,095,562
Yon Jorden
Director
Mar 13, 2026Award+13,096––105,830
James M. Head
Chief Financial Officer
Mar 13, 2026Award+103,002––184,595
Christopher J. Joyce
Chief Legal and Admin. Officer
Mar 13, 2026Award+51,501––348,589
David C. Hodgson
Director
Mar 13, 2026Award+18,982––173,408
Joseph S. Konowiecki
Director
Mar 13, 2026Award+24,868––1,081,009
Hyong Kim
Chief Medical Officer
Mar 13, 2026Award+52,972––386,105
John E. Kao
Chief Executive Officer, Director
Mar 13, 2026Award+338,434––1,857,914
Jody L. Bilney
Director
Mar 13, 2026Award+16,039––129,267
Andreas P. Wagner
Chief Human Resources Officer
Mar 13, 2026Award+23,543––172,230
Adnan R. Mansour
Chief Digital Officer
Mar 13, 2026Award+25,015––48,456
Margaret M. McCarthy
Director
Mar 13, 2026Award+14,273––144,441
Mark B. McClellan
Director
Mar 13, 2026Award+13,096––370,531

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
11.59%
23M shares short
Days to cover
3.9
At 6M shares a day
Change since last report
-9.3%
From 26M shares
Short volume, 20 days
36.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Alignment Healthcare's stock actually held short. Settlement fails (shares not delivered on time) peaked at 615,856 shares on Sep 25, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Joseph S. Konowiecki
Chairman / EVP, Corporate Affairs
Nov 9, 20265,500$39.99KNov 10, 2026The Common Stock was acquired through the vesting of restricted stock units granted on 11/07/2022 under the Issuer's 2021 Equity Incentive Plan
Hyong Kim
Chief Medical Officer
Oct 5, 202636,000$305.28KOct 6, 2026The Common Stock was acquired through the vesting of restricted stock units granted on 10/04/2023 under the Issuer's 2021 Equity Incentive Plan
Joseph S. Konowiecki
Director / EVP, Corporate Affairs
Sep 16, 202626,000$226.46KSep 17, 2026The Common Stock was acquired through the vesting of restricted stock units granted on 09/14/2023 under the Issuer's 2021 Equity Incentive Plan
Jek Trust U/A Dtd 02/08/2021
Director, Officer
Sep 10, 2026500,000$6.52MSep 10, 2026Shares Issued Pre-IPO in exchange for Partnership Units
Dawn Christine Maroney
President
Sep 9, 2026130,000$1.70MSep 10, 2026The Common Stock was acquired through the vesting of restricted stock units granted on 09/12/2022 under the Issuer's 2021 Equity Incentive Plan
John E. Kao
Chief Executive Officer / Director
Sep 9, 2026405,000$5.29MSep 10, 2026The Common Stock was acquired through the vesting of restricted stock units granted on 09/12/2022 under the Issuer's 2021 Equity Incentive Plan
Dawn Christine Maroney
Officer
Aug 14, 20265,000$67.30KAug 14, 2026RSU/PSU
Dawn Christine Maroney
Officer
Jul 15, 2026177,068$3.75MJul 15, 2026Exercise of Stock Options
Jek Trust U/A Dtd 02/08/2021
Director, Officer
Jul 10, 2026596,000$12.53MJul 10, 2026Shares Issued Pre-IPO in exchange for Partnership Units
Joseph S. Konowiecki
Director
Jul 1, 202625,000$600.00KJul 1, 2026Stock Bonus
Joseph S. Konowiecki
Director
Jun 26, 202625,000$575.00KJun 26, 2026Stock Bonus
Joseph S. Konowiecki
Director
Jun 18, 202625,000$550.00KJun 18, 2026Stock Bonus
Sebastian Burzacchi
Officer
Jun 12, 20261,142$23.11KJun 12, 2026Restricted Stock Units
Hyong Kim
Officer
Jun 12, 202635,951$727.65KJun 12, 2026Restricted Stock Units
Joseph S. Konowiecki
Director
Jun 11, 202625,000$525.00KJun 11, 2026Stock Bonus

See a number that looks wrong?